IKNA – ikena oncology, inc. (US:NASDAQ)

News

Ikena Oncology, Inc. (NASDAQ: IKNA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update [Yahoo! Finance]
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
Avalyn Bolsters Leadership Team with the Appointment of Douglas Carlson as Chief Financial Officer and Chief Business Officer [Yahoo! Finance]
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com